Schistosomiasis affects over 200 million people globally, complicating health, especially in liver transplant patients.
There are limited reports on Schistosoma mansoni in liver transplants and its long-term impact on the graft.
Two cases demonstrated abnormal liver enzymes in transplant recipients, with improvement following antiparasitic treatment and highlighted the need for screening in potential transplant patients from endemic regions.